Any studies that do exist tend to be small
doi: 10.1084/jem.20162024 48 ZeisbergMKalluriR
There are consequences in taking glp-1 medications
Free Radic Biol Med 2017;106:1117 [DOI] [PMC free article] [PubMed] [Google Scholar] 46.Sun J, Wen Y, Zhou Y, Jiang Y, Chen Y, Zhang H, Guan L, Yao X, Huang M, Bi H.p53 attenuates acetaminophen-induced hepatotoxicity by regulating drug-metabolizing enzymes and transporter expression
Between Q4 2024 and Q1 2025, the share of Medicare patients with comorbid diabetes or obesity and MASLD who started a GLP1 rose from 13% to 19%, compared with only a modest increase from 20% to 22% among commercially insured patients
Our healthcare professionals develop tailored treatment plans, integrating Ozempic or Tirzepatide with healthy lifestyle changes and balanced nutrition to achieve optimal glycemic control and improved cardiovascular health